Robuta

https://www.m-ventures.com/news/enara-bio-to-unveil-first-in-class-darkfox-targeting-bispecific-t-cell-engager-ena101-in-oral-presentation-at-aacr-2026-showcasi Enara Bio to Unveil First‑in‑Class DARKFOX‑Targeting Bispecific T Cell Engager ENA101 in Oral... t cellenarabiounveilengager https://enarabio.com/ Advancing cancer immunotherapy by targeting the unconventional - Enara Bio cancer immunotherapyadvancingtargetingunconventionalenara